Tissue Engineering Is Fastest Growing Segment Fueling The Growth Of Stem Cell Manufacturing Market


The global Stem Cell Manufacturing Market is estimated to be valued at US$ 12415.84 Mn in 2023 and is expected to exhibit a CAGR of 13.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Stem cell manufacturing involves production of stem cells through various processes such as cell isolation, cryopreservation and cell packaging. The increasing research and development activities for treatment of various chronic diseases and disorders such as cancer, cardiovascular diseases, diabetes among others through stem cell and tissue engineering applications is driving the growth of the stem cell manufacturing market.

Market key trends:
One of the key trends driving the growth of stem cell manufacturing market is increasing research activities for development of personalized medicine. Several research institutes and pharmaceutical companies have started focusing on development and production of patient-specific stem cell products which can cure chronic diseases more effectively with lesser side effects by considering individual genetic variations. This is expected to boost the demand for stem cell manufacturing over the forecast period.

Segment Analysis

The global stem cell manufacturing market is segmented into tools, cell lines, culture media, and other consumables. The cell lines segment currently dominates the market as they provide unrestricted access to stem cells for research and therapeutic applications. This segment is expected to continue its dominance over the forecast period owing to the ability of cell lines to expand indefinitely and their widespread adoption in developing novel cell-based therapies.

Key Takeaways
The Global Stem Cell Manufacturing Market Size is expected to witness high growth, exhibiting a CAGR of 13.3% over the forecast period, due to increasing incidence of chronic diseases and growing demand for regenerative medicines.

Regional analysis
North America is expected to dominate the global stem cell manufacturing market over the forecast period. This is attributed to the presence of advanced healthcare infrastructure, higher healthcare spending, increasing stem cell research activities, and supportive regulatory environment in the region. Asia Pacific is anticipated to exhibit the fastest growth during the forecast period owing to rising medical tourism, growing geriatric population, and improving healthcare infrastructure.

Key players
Key players operating in the stem cell manufacturing market are TAKARA BIO Inc., PHARMICELL Co., Ltd., MEDIPOST Co., Holostem Terapie Avanzate S.r.l, Bio-Rad Laboratories, Anterogen Co., Ltd., Osiris Therapeutics, Inc (Smith & Nephew PLC), Minaris Regenerative Medicine (Hitachi Chemical Co., Ltd.), Nikon CeLL Innovation Co. Ltd. (Nikon Corporation), Medinet Co. Ltd., Cell and Gene Therapy Catapult, Bio Elpida, Miltenyi Biotec, Pluristem Therapeutics Inc., Thermo Fischer Scientific, Merck Group, Corning Incorporated, Stem Cell Technologies, Lonza Group, Becton, Dickinson and Company, Sartorius, and Cellular Dynamics (Fujifilm Holdings Corporation, among others.

Read More: https://www.ukwebwire.com/stem-cell-manufacturing-market-size-share-and-growth-forecast-2023-2023/

Comments

Popular posts from this blog

Contact Center Software Market Growth Accelerated by Enhanced Customer Experience

Microscale 3D Printing Market Growth Accelerated by Advanced Manufacturing Techniques

The Global Seismic Survey Market Growth Accelerated by Increased Oil and Gas E&P Activities